|
May 20
|
Heard on the Street: Hims Is Jumping on a Crowded Ozempic Bandwagon
|
|
May 20
|
Hims & Hers Health to Offer Injectable Weight-Loss Drugs on Telehealth Platform
|
|
May 20
|
Weight loss: Hims & Hers introduce access to GLP-1 injections
|
|
May 20
|
Hims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
|
|
May 16
|
Hims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
|
|
May 15
|
High Insider Ownership Growth Stocks On US Exchange For May 2024
|
|
May 9
|
Results: Hims & Hers Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts
|
|
May 7
|
Oscar Health, Kenvue, Hims & Hers: Health earnings roundup
|
|
May 7
|
Telehealth Stock Gains Popularity With Options Bulls
|
|
May 6
|
Him & Hers Health stock soars on Q1 revenue beat, Q2 guidance
|
|
May 6
|
Hims & Hers Health, Inc. Reports First Quarter 2024 Financial Results
|
|
Apr 16
|
Jefferies downgrades Hims & Hers Health on growth concerns
|
|
Apr 15
|
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
|
|
Apr 3
|
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
|
|
Mar 22
|
Nvidia's valuation forecasts aren't 'justified': Portfolio manager
|
|
Mar 11
|
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
|
|
Feb 5
|
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
|
|
Jan 11
|
Hims & Hers Teams with Hartford HealthCare to Connect People to In-person Care
|
|
Dec 4
|
Hims & Hers Launches Holistic Weight Loss Program to Break the Endless Cycle of Weight Gain and Loss
|
|
Nov 6
|
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
|